Showing results (1331-1340 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|September 30, 2023
Automated Classification of Quality Defect Issues Relating to Substandard Medicines Using a Hybrid Machine Learning and Rule-Based ApproachDesmond Chun Hwee Teo, Yiting Huang, Sreemanee Raaj Dorajoo, et al.Drug Safety|June 19, 2023
Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012-2019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting RatePatrick E Beeler, Thomas Stammschulte, Holger DresselDrug Safety|June 17, 2023
Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing TechniquesSiun Kim, Taegwan Kang, Tae Kyu Chung, et al.Drug Safety|January 5, 2019
Managing Risks with Immune Therapies in Multiple SclerosisMoritz Förster, Patrick Küry, Orhan Aktas, et al.Drug Safety|January 17, 2019
Adverse Drug Events Detection in Clinical Notes by Jointly Modeling Entities and Relations Using Neural NetworksBharath Dandala, Venkata Joopudi, Murthy DevarakondaDrug Safety|January 17, 2019
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in CancerIosune Baraibar, Ignacio Melero, Mariano Ponz-Sarvise, et al.Drug Safety|January 17, 2019
Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic ConstipationPhilip B MinerDrug Safety|January 17, 2019
Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in OncologyGiuseppe Curigliano, Rashmi R ShahDrug Safety|January 17, 2019
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled AsthmaMats Carlsson, Martin Braddock, Yuling Li, et al.Drug Safety|September 25, 2020
Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New ZealandJoanne Barnes, Rachael ButlerPageof 311